The ectonucleotidases CD 39 and CD 73: novel checkpoint inhibitor targets

B Allard, MS Longhi, SC Robson… - Immunological …, 2017 - Wiley Online Library
Cancers are able to grow by subverting immune suppressive pathways, to prevent the
malignant cells as being recognized as dangerous or foreign. This mechanism prevents the …

Pharmacology of adenosine receptors: the state of the art

PA Borea, S Gessi, S Merighi… - Physiological …, 2018 - journals.physiology.org
Adenosine is a ubiquitous endogenous autacoid whose effects are triggered through the
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …

[HTML][HTML] GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

S Talukdar, EJ Bae, T Imamura, H Morinaga, WQ Fan… - Cell, 2010 - cell.com
Summary Omega-3 fatty acids (ω-3 FAs), DHA and EPA, exert anti-inflammatory effects, but
the mechanisms are poorly understood. Here, we show that the G protein-coupled receptor …

Adenosine receptors as drug targets—what are the challenges?

JF Chen, HK Eltzschig, BB Fredholm - Nature reviews Drug discovery, 2013 - nature.com
Adenosine signalling has long been a target for drug development, with adenosine itself or
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …

Adenosine receptors as therapeutic targets

KA Jacobson, ZG Gao - Nature reviews Drug discovery, 2006 - nature.com
Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the
world. There is growing evidence that they could also be promising therapeutic targets in a …

Immunity, inflammation and cancer: a leading role for adenosine

L Antonioli, C Blandizzi, P Pacher, G Haskó - Nature Reviews Cancer, 2013 - nature.com
Cancer is a complex disease that is dictated by both cancer cell-intrinsic and cell-extrinsic
processes. Adenosine is an ancient extracellular signalling molecule that can regulate …

Purinergic signalling in the nervous system: an overview

MP Abbracchio, G Burnstock, A Verkhratsky… - Trends in …, 2009 - cell.com
Purinergic receptors, represented by several families, are arguably the most abundant
receptors in living organisms and appeared early in evolution. After slow acceptance …

Extracellular adenosine triphosphate and adenosine in cancer

J Stagg, MJ Smyth - Oncogene, 2010 - nature.com
Adenosine triphosphate (ATP) is actively released in the extracellular environment in
response to tissue damage and cellular stress. Through the activation of P2X and P2Y …

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

J Stagg, U Divisekera, H Duret, T Sparwasser… - Cancer research, 2011 - AACR
CD73 is a cell-surface enzyme that suppresses immune responses by producing
extracellular adenosine. In this study, we employed CD73 gene-targeted mice to investigate …

Molecular mechanism of action and pharmacokinetic properties of methotrexate

V Maksimovic, Z Pavlovic-Popovic, S Vukmirovic… - Molecular biology …, 2020 - Springer
Since its discovery in 1945, methotrexate has become a standard therapy for number of
diseases, including oncological, inflammatory and pulmonary ones. Major physiological …